Docklands growth dominates strategy

By James Whitmore, Clayton Hirst, James Whitmore Clayton Hirst5 March 1999

The prospect of a huge £6bn property company dominating the central London office market would be mouth-watering for investors, who are starved of a property equivalent to BP Amoco or GlaxoWellcome.

This content is only available to registered users

You must be logged in to continue

Would you like to read more?

Register for free to finish this article

Registration includes the following benefits:

Access up to four FREE articles per month
Breaking news, comment and analysis from industry experts as it happens
Choose from our portfolio of email newsletters

To access this article REGISTER NOW

Four articles not enough? SUBSCRIBE for unlimited access to over 100 weekly articles and our comprehensive archive. For as little as £5 per week.

Registered users and subscribers SIGN IN here to continue